Design Therapeutics, Inc. (DSGN)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Design Therapeutics, Inc. reported revenue of $0. The company ran a net loss. It held $226.20M in total assets against $13.70M in total liabilities.
Key ratios (FY2025)
-32.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — | — |
| Operating Income | -$79.47M | -$62.38M | -$78.19M | -$67.59M | -$35.83M | -$8.33M | — |
| Net Income | -$69.79M | -$49.59M | -$66.86M | -$63.31M | -$35.53M | -$8.28M | — |
| EPS (Diluted) | $-1.22 | $-0.88 | $-1.19 | $-1.14 | $-0.77 | — | — |
| Total Assets | $226.20M | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | — |
| Total Liabilities | $13.70M | $10.00M | $11.96M | $13.83M | $8.43M | $2.48M | — |
| Shareholders' Equity | $212.50M | $242.10M | $277.69M | $327.31M | $382.13M | -$11.31M | -$3.64M |
| Cash & Equivalents | $16.86M | $22.56M | $21.20M | $26.50M | $298.57M | $2.38M | — |
| Operating Cash Flow | -$54.36M | -$43.10M | -$58.56M | -$51.32M | -$29.38M | -$8.67M | — |
| Capital Expenditures | $193.0K | $340.0K | $256.0K | $918.0K | $1.54M | $76.0K | — |
| Shares Outstanding | 60.40M | 56.75M | 56.47M | 55.90M | 55.44M | 15.96M | — |